Published on
September 1, 2025
- 20:25 GMT
JLS Fund Congratulates Largest Portfolio Holding, Gilamesh Pharmaceuticals on $1.2 Billion Deal with AbbVie (NYSE: ABBV)
$1.2 Billion deal just the beginning for Gilgamesh and JLS Fund NEW YORK, NY, UNITED STATES, September 1, 2025 /EINPresswire.com/ -- JLS Fund I, a Neuromedicine fund focused on neuroscience, mental health and enabling tools and infrastructure, is …
Distribution channels:
Banking, Finance & Investment Industry
...
